Loading...
LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency
Familial LCAT deficiency (FLD) is due to mutations in lecithin:cholesterol acyltransferase (LCAT), a plasma enzyme that esterifies cholesterol on lipoproteins. FLD is associated with markedly reduced levels of plasma high-density lipoprotein and cholesteryl ester and the formation of a nephrotoxic l...
Na minha lista:
| Udgivet i: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6374542/ https://ncbi.nlm.nih.gov/pubmed/30563940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.118.251876 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|